ITMO public health
Last update : 09/19/2017 | Version : 1 | ID : 73177
| General | |
| Identification | |
| Detailed name | PrimInject: cross-sectional study on the patterns and practices of drug use in France |
| General Aspects | |
| Medical area |
Infectious diseases |
| Health determinants |
Addictions Lifestyle and behavior |
| Scientific investigator(s) (Contact) | |
| Name of the director | Arwidson |
| Surname | Pierre |
| Address |
12, rue du Val d'Osne 94415 Saint-Maurice cedex |
| pierre.arwidson@santepubliquefrance.fr | |
| Organization | Santé publique France |
| Name of the director | Guignard |
| Surname | Romain |
| Address |
12, rue du Val d'Osne 94415 Saint-Maurice cedex |
| Phone | 0171801575 |
| romain.guignard@santepubliquefrance.fr | |
| Organization | Santé publique France |
| Name of the director | Guichard |
| Surname | Anne |
| Organization | Université Laval, Québec |
| Collaborations | |
| Participation in projects, networks and consortia |
No |
| Funding | |
| Funding status |
Public |
| Details | Inpes |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Santé publique France |
| Organisation status |
Public |
| Presence of scientific or steering committees |
Yes |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Online recruitment of participants |
| Database objective | |
| Main objective |
Intravenous injection is the major mode of transmission of HCV among drug users, not only by needle sharing but also by the preparation equipment (container, filter, buffer, water), potentially contaminated by the blood of a contaminated person.
According to various sources, in recent years there have been significant changes in the patterns and practices of drug use in France, under the combined effect of the massive distribution of opiate substitution treatments (high-dose buprenorphine or BHD) from 1995 and the introduction of a wide variety of stimulants, including cocaine and synthetic drugs. Often unplanned and practiced by a third party "initiator", the first injections present a high risk of contamination for the young initiate, often not well acquainted with injection techniques and the infectious risks and not in contact with first-line medical support structures. In this context, a survey was put in place to identify the circumstances and practices of the first injection(s) among young drug users in France. An online methodology using the Internet has been developed to provide access and thus to discover user profiles that escape the more "classic" observation systems, especially those that are socially integrated or that are not in contact with support structures. |
| Inclusion criteria | Be over 15 years old. Individuals who had never injected drugs were redirected to a short version of the questionnaire. |
| Population type | |
| Age |
Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) |
| Population covered |
General population |
| Pathology | |
| Gender |
Male Woman |
| Geography area |
National |
| Detail of the geography area | France |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | October 2010 |
| Date of last collection (YYYY or MM/YYYY) | March 2011 |
| Size of the database | |
| Size of the database (number of individuals) |
[500-1000[ individuals |
| Details of the number of individuals | 449 injectors and 455 non-injectors |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Declarative data |
| Declarative data (detail) |
Internet self-questionnaire |
| Details of collected declarative data | Sociodemographic data, uses of psychoactive substances, practices and attitudes related to the first injection, HIV and HCV infection |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/morbidity Others |
| Other (detail) | Uses of psychoactive substances, practices and attitudes related to the first injection |
| Procedures | |
| Data collection method | Internet. Promotion of the survey via a campaign of web banners, posters in cart-com format, articles and press releases. |
| Quality procedure(s) used | Pre-test of tools and questionnaire for intravenous drug users. Verification and cleaning of the database in Stata. |
| Participant monitoring |
No |
| Followed pathology | |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/23726980 |
| Description | Practices related to the first injection according to the key periods of the risk reduction policy in France. Article published in Drug and Alcohol Dependence. |
| Link to the document | http://www.federationaddiction.fr/actal-n10-decembre-2011-hepatites-de-reelles-avancees/ |
| Description | The first injection in the risk reduction prism. Article published in the Actal journal of the Fédération Addiction. |
| Access | |
| Presence of document that lists variables and coding procedures |
No |
| Terms of data access (charter for data provision, format of data, availability delay) | On request from Pierre Arwidson, Director of Scientific Affairs at Inpes. |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
| ABOUT | CATALOG | RESOURCES | USEFUL LINKS |
This site complies with the HONcode standard for trustworthy health information: |
8 rue de la Croix Jarry 75013 Paris Phone : +33 1 44 23 67 47 |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05
